Idiopathic intracranial hypertension (pseudotumor cerebri)

Insight - Journal of the American Society of Ophthalmic Registered Nurses

Volumn 33, Issue 2, 2008, Pages 18-25

  Wall, Michael ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ANTIINFLAMMATORY AGENT; DIURETIC AGENT; DRUG DERIVATIVE; FRUCTOSE; FUROSEMIDE; NEUROPROTECTIVE AGENT; TOPIRAMATE;

ARTICLE; BRAIN PSEUDOTUMOR; CEREBROSPINAL FLUID SHUNTING; CRANIAL SINUS; DIFFERENTIAL DIAGNOSIS; DIPLOPIA; EYE MOVEMENT DISORDER; HEADACHE; HUMAN; INCIDENCE; OPHTHALMOSCOPY; OPTIC NERVE; PERIMETRY; PUNCTURE; RISK FACTOR; TINNITUS; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL DISORDER; WEIGHT REDUCTION;

ACETAZOLAMIDE; ANTI-INFLAMMATORY AGENTS; CEREBROSPINAL FLUID SHUNTS; CRANIAL SINUSES; DIAGNOSIS, DIFFERENTIAL; DIPLOPIA; DIURETICS; FRUCTOSE; FUROSEMIDE; HEADACHE; HUMANS; INCIDENCE; NEUROPROTECTIVE AGENTS; OCULAR MOTILITY DISORDERS; OPHTHALMOSCOPY; OPTIC NERVE; PERIMETRY; PSEUDOTUMOR CEREBRI; RISK FACTORS; SPINAL PUNCTURE; TINNITUS; TREATMENT OUTCOME; VISION, LOW; VISUAL ACUITY; WEIGHT LOSS;

EID: 47049090609     PISSN: 1060135X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Durcan F.J., Corbett J. J., & Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol 1988; 45:875-877.
2. Garrett J., Corbett J. J., Braswell R. A., & Santiago M. The increasing incidence of IIH. The effect of obesity on frequency of occurrence in Mississippi. Ann Neurol 2004; 56(Suppl 8):S69.
3. Daniels A. B., Liu G. T., Volpe N. J., Galetta S. L., Moster M. L., & Newman N. J. et al. Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol 2007; 143(4):635-641.
4. Balcer L. J., Liu G. T., Forman S., Pun K., Volpe N. J., & Galetta S. L. et al. Idiopathic intracranial hypertension: Relation of age and obesity in children. Neurology 1999; 52(4):870-872.
5. Digre K. B., & Corbett J. J. Pseudotumor cerebri in men. Arch Neurol 1988; 45:866-872.
6. Ireland B., Corbett J. J., & Wallace R. B. The search for causes of idiopathic intracranial hypertension. A preliminary case-control study. Arch Neurol 1990; 47:315-320.
7. Giuseffi V., Wall M., Siegel P. Z., & Rojas P. B. Symptoms and disease associations in idiopathic intracranial hypertension (pseudotumor cerebri): A case-control study. Neurology 1991; 41:239-244.
8. Boulton M., Armstrong D., Flessner M., Hay J., Szalai J. P., & Johnston M. Raised intracranial pressure increases CSF drainage through arachnoid villi and extracranial lymphatics. Am J Physiol 1998; 275 (3 Pt 2):889-896.
9. Sahs A. L., & Joynt R.J. Brain swelling of unknown cause. Neurology 1956; 6:791-803.
10. Wall M., Dollar J. D., Sadun A. A., & Kardon R. Idiopathic intracranial hypertension: Lack of histologic evidence for cerebral edema. Arch Neurol 1995; 52:141-145.
11. Wall M. The headache profile of idiopathic intracranial hypertension. Cephalalgia 1990; 10:331-335.
12. Friedman D. I., & Rausch E. A. Headache diagnoses in patients with treated idiopathic intracranial hypertension. Neurology 2002; 58(10):1551-1553.
13. Meador K. J., & Swift T. R. Tinnitus from intracranial hypertension. Neurology 1984; 34:1258-1261.
14. Farb R. I., Vanek I., Scott J. N., Mikulis D. J., Willinsky R. A., & Tomlinson G. et al. Idiopathic intracranial hypertension: The prevalence and morphology of sinovenous stenosis. Neurology 2003; 60(9):1418-1424.
15. Wall M., & White W. N. Asymmetric papilledema in idiopathic intracranial hypertension: Prospective interocular comparison of sensory visual function. Invest Ophthalmol Vis Sci 1998; 39(1):134-142.
16. Wall M., & George D. Idiopathic intracranial hypertension. A prospective study of 50 patients. Brain 1991; 114:155-180.
17. Smith J. L. Whence pseudotumor cerebri? J Clin Neuro-ophthalmol 1985; 5:55-56.
18. Neville L., & Egan R. A. Frequency and amplitude of elevation of cerebrospinal fluid resting pressure by the Valsalva maneuver. Can J Ophthalmol 2005; 40(6):775-777.
19. Whiteley W., Al Shahi R., Warlow C. P., Zeidler M., & Lueck C. J. CSF opening pressure: Reference interval and the effect of body mass index. Neurology 2006; 67(9):1690-1691.
20. Bono F., & Quattrone A. CSF opening pressure: Reference interval and the effect of body mass index. Neurology 2007; 68(17): 1439-1440.
21. Corbett J. J., Mehta M. P. Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri. Neurology 1983; 33:1386-1388.
22. Bono F., Lupo M. R., Serra P., Cantafio C., Lucisano A., & Lavano A. et al. Obesity does not induce abnormal CSF pressure in subjects with normal cerebral MR venography. Neurology 2002; 59(10):1641-1643.
23. Yeh Y. C., Tang H. F., & Fang I. M. Pseudotumor cerebri caused by all-trans retinoic acid treatment for acute promyelocytic leukemia. Jpn J Ophthalmol 2006; 50(3):295-296.
24. Winn B. J., Liao Y. J., & Horton J. C. Intracranial pressure returns to normal about a month after stopping tetracycline antibiotics. Arch Ophthalmol 2007; 125(8):1137-1138.
25. Ang E. R., Zimmerman J. C., & Malkin E. Pseudotumor cerebri secondary to minocycline intake. Journal of the American Board of Family Practice 2002; 15(3):229-233.
26. Wall M. Papilledema and Idiopathic Intracranial Hypertension (Pseudotumor Cerebri). In: Noseworthy J. H. (Ed.) Neurological Therapeutics Principles and Practice. Abingdon, UK: Informa Healthcare, 2006: 1955-1968.
27. Newborg B. Pseudotumor cerebri treated by rice-reduction diet. Arch Intern Med 1974; 133:802-807.
28. Johnson L. N., Krohel G. B., Madsen R. W., & Match G. A., Jr. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology 1998; 105(12):2313-2317.
29. Kupersmith M. J., Gamell L., Turbin R., Peck V., Spiegel P., & Wall M. Effects of weight loss on the course of idiopathic intracranial hypertension in women. Neurology 1998; 50(4):1094-1098.
30. Wong R., Madill S. A., Pandey P., & Riordan-Eva P. Idiopathic intracranial hypertension: The association between weight loss and the requirement for systemic treatment. BMC Ophthalmol 2007; 7(1):15.
31. Sugerman H. J., Felton W. L., III, Sismanis A., Kellum J. M., DeMaria E. J., & Sugerman E. L. Gastric surgery for pseudotumor cerebri associated with severe obesity. Ann Surg 1999; 229(5):634-640.
32. Johnston I., & Paterson A. Benign intracranial hypertension. II. CSF pressure and circulation. Brain 1974; 97:301-312.
33. Scoffings D. J., Pickard J. D., & Higgins J. N. Resolution of transverse sinus stenoses immediately after CSF withdrawal in idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry 2007; 78(8):911-912.
34. McCarthy K. D., & Reed D. J. The effect of acetazolamide and furosemide on CSF production and choroid plexus carbonic anhydrase activity. J Pharmacol Exp Ther 1974; 189:194-201.
35. Gücer G., & Vierenstein L. Long-term intracranial pressure recording in management of pseudotumor cerebri. J Neurosurg 1978; 49:256-263.
36. Tomsak R. L., Niffenegger A. S., & Remler B. F. Treatment of pseudotumor cerebri with Diamox (acetazolamide). J Clin Neuro-Ophthalmol 1988; 8:93-98.
37. Celebisoy N., Gokcay F., Sirin H., & Akyurekli O. Treatment of idiopathic intracranial hypertension: Topiramate vs. acetazolamide, an open-label study. Acta Neurol Scand 2007; 116(5):322-327.
38. Zimran A., & Beutler E. Can the risk of acetazolamide-induced aplastic anemia be decreased by periodic monitoring of blood cell counts? Am J Ophthalmol 1987; 104(6):654-658.
39. Shah V. A., Fung S., Shahbaz R., Taktakishvili O., Wall M., & Lee A. G. Idiopathic intracranial hypertension. Ophthalmology 2007; 114(3):617.
40. Corbett J. J. The 1982 Silversides lecture. Problems in the diagnosis and treatment of pseudotumor cerebri. Can J Neurol Sci 1983; 10:221-229.
41. Pollay M., Fullenwider C., Roberts P. A., & Stevens F. A. Effect of mannitol and furosemide on blood-brain osmotic gradient and intracranial pressure. J Neurosurg 1983; 59(6):945-950.
42. Kessler L. A., Novelli P. M., & Reigel D. H. Surgical treatment of benign intracranial hypertension - subtemporal decompression revisited. Surg Neurol 1998; 50(1):73-76.
43. Goh K. Y., Schatz N. J., & Glaser J. S. Optic nerve sheath fenestration for pseudotumor cerebri. J Neuro-Ophthalmol 1997; 17(2):86-91.
44. Acheson J. F., Green W. T., & Sanders M. D. Optic nerve sheath decompression for the treatment of visual failure in chronic raised intracranial pressure. J Neurol Neurosurg Psychiatr 1994; 57(11):1426-1429.
45. Sergott R. C., Savino P. J., & Bosley T. M. Modified optic nerve sheath decompression provides long-term visual improvement for pseudotumor cerebri. Arch Ophthalmol 1988; 106:1391-1397.
46. Corbett J. J., Nerad J. A., Tse D., & Anderson R. L. Optic nerve sheath fenestration for pseudotumor cerebri: The lateral orbitotomy approach. Arch Ophthalmol 1988; 106:1391-1397.
47. Plotnik J. L., & Kosmorsky G. S. Operative complications of optic nerve sheath decompression. Ophthalmology 1993; 100(5):683-690.
48. Brourman N. D., Spoor T. C., & Ramocki J. M. Optic nerve sheath decompression for pseudotumor cerebri. Arch Ophthalmol 1988; 106:1378-1383.
49. Chandrasekaran S., McCluskey P., Minassian D., & Assaad N. Visual outcomes for optic nerve sheath fenestration in pseudotumour cerebri and related conditions. Clin Experiment Ophthalmol 2006; 34(7):661-665.
50. Curry W. T., Jr., Butler W. E., & Barker F. G. Rapidly rising incidence of cerebrospinal fluid shunting procedures for idiopathic intracranial hypertension in the United States, 1988-2002. Neurosurgery 2005; 57(1):97-108.
51. Eggenberger E. R., Miller N. R., & Vitale S. Lumboperitoneal shunt for the treatment of pseudotumor cerebri. Neurology 1996; 46(6):1524-1530.
52. Rosenberg M., Smith C., & Beck R. The efficacy of shunting procedures in pseudotumor cerebri. Neurology 1989; 39:209.
53. Burgett R. A., Purvin V. A., & Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri. Neurology 1997; 49(3):734-739.
54. Johnston I., Besser M., & Morgan M. K. Cerebrospinal fluid diversion in the treatment of benign intracranial hypertension. J Neurosurg 1988; 69:195-202.
55. McGirt M. J., Woodworth G., Thomas G., Miller N., Williams M., & Rigamonti D. Cerebrospinal fluid shunt placemint for pseudotumor cerebri-associated intractable headache: Predictors of treatment response and an analysis of long-term outcomes. Journal of Neurosurgery 2004, 101(4):627-32.
56. King J. O., Mitchell P. J., Thomson K. R., & Tress B. M. Manometry combined with cervical puncture in idiopathic intracranial hypertension. Neurology 2002; 58(1):26-30.
57. Friedman D. I. Cerebral venous pressure, intra-abdominal pressure, and dural venous sinus stenting in idiopathic intracranial hypertension. J Neuroophthalmol 2006; 26(1):61-64.